Skip to main content
SpringerLink
Log in

Transmission of Resistant Viruses

  • Conference paper
HIV-Infekt

  • 174 Accesses

Abstract

Consensus guidelines advise to treat HIV-infected persons with at least three anti-retroviral drugs. In many patients such a combination therapy has resulted in a significant suppression of HIV-replication and clinical improvement. However when a high viral load persists and/or CD4+cell count declines despite therapy, drug-absorption problems, non-compliance or resistance should be suspected. Resistance of HIV-i has now been reported to all available antiretroviral agents (non-nucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors and protease inhibitors) [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mayers DL (1997) Prevalence and incidence of resistance to zidovudine and other antiretroviral drugs. Am J Med. 102 (5B): 70–75.

    Article  PubMed  CAS  Google Scholar 

  2. Birk M, Sönnerborg A (1998) Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment naive-patients. AIDS 12: 2369–2375.

    Article  PubMed  CAS  Google Scholar 

  3. Wainberg MS, Friedland G (1998) Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 279: 1977–1983.

    Article  PubMed  CAS  Google Scholar 

  4. De Jong MF, Schuurman R, Lange JMA, Boucher CAB (1996) Replication of a pre-existing resistant HIV-1 subpopulation in vivo after introduction of a strong selective drug pressure. Antiviral Therapy 1: 33–41

    PubMed  Google Scholar 

  5. Erice A, Mayers DL, Strike DG, Sannerud K, McCutchan FE, Henry K, Balfour HH (1993) Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Eng J Med 16: 1163–1165.

    Article  Google Scholar 

  6. Taylor S, Back DJ, Workman J, Drake SM, White DJ, Choudhury B, Cane PA, Beards GM, Halifax K, Pillay D (1999) Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS 13: 859–860.

    Article  PubMed  CAS  Google Scholar 

  7. Byrn RA, Zhang D, Eyre R, McGowan K, Kiessling AA (1997) HIV in semen: an isolated virus reservoir. Lancet 350: 1141.

    Article  PubMed  CAS  Google Scholar 

  8. Kroodsma KL, Kozal MJ, Hamed KA, Winters MA, Merigan TC (1994) Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. J Infect Dis 170: 1292–1295.

    Article  PubMed  CAS  Google Scholar 

  9. Eron JJ, Vernazza PL, Johnston DM, Seillier-Moiseiwitsch F, Alcorn TM, Fiscus SA, Cohen MS (1998) Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS 12: F181–F189.

    Article  PubMed  CAS  Google Scholar 

  10. Liuzzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, Tullio Cataldo P, Piazza M (1996) Analysis of HIV-1 load in blood semen and saliva: evidence for different viral compartments in a cross- sectional and longitudinal study. AIDS 10: F51–F56.

    Article  PubMed  CAS  Google Scholar 

  11. Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsztejn L, Heard I, Jouannet P, Sicard D, Rouzioux C (1999) Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 13: 823–831.

    Article  PubMed  CAS  Google Scholar 

  12. Alexander C, Dong W, Schechter, MT, O’Shaugnessy MV, Strathdee S, Mo T, Montaner JSG, Harrigan PR (1999) Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users. AIDS 13: 981–985.

    Article  PubMed  CAS  Google Scholar 

  13. Centers for Disease Control (1998) Public health service task force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR 47: 1–30.

    Google Scholar 

  14. The Italian Register for HIV infection in children (1999) Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. AIDS 13: 927–933

    Article  Google Scholar 

  15. Colgrove R, Pitt J, Japour A, Welles S (1999) Zidovudine resistance after vertical transmission of HIV-1. Abstract 265 at the 6th conference on Retroviruses and Opportunistic Infections. Chicago USA.

    Google Scholar 

  16. Johnson VA, Wooods C, Hamilton CD, Fiscus SA (1999) Vertical transmission of an HIV-i variant resistant to multiple reverse transcriptase and protease inhibitors. Abstract 266 at the 6th conference on Retroviruses and Opportunistic Infections. Chicago USA.

    Google Scholar 

  17. Eastman PS, Shapiro DE, Coombs RW, Frenkel LM, McSherry GD, Britto P, Herman SA, Sperling RS (1998) Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS clinical trials group protocol 076. J Infect Dis 177: 557–564.

    Article  PubMed  CAS  Google Scholar 

  18. Kully C, Yerly S, Erb P, Kind C, Krautheim A, Perrin L, Rudin C and the Swiss collaborative ‘HIV and Pregnancy’ Study (1999) Codon 215 mutations in Human Immunodeficiency Virus infected pregnant women. J Infect Dis 179: 705–708.

    Google Scholar 

  19. Colgrove RC, Pitt J, Chung PH, Welles S, Japour AJ (1998) Selective vertical transmission of HIV-1 antiretroviral resistance mutations. AIDS 12: 2281–2288.

    Article  PubMed  CAS  Google Scholar 

  20. Wolinsky SM, Wike CM, Korber BTM, Hutto C, Parks WP, Rosenblum LL, Kunstman KJ, Furtado MR, Munoz JL (1992) Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255: 1134–1137.

    Article  PubMed  CAS  Google Scholar 

  21. Wahlberg J, Fiore J, Anarano G, Uhlen M, Albert J (1994) Apparent selection against transmission of zidovudine-resistant human immunodefkieny virus type 1 variants. J Infect Dis 169: 611–614.

    Article  PubMed  CAS  Google Scholar 

  22. Ribeiro, RM, Bonhoeffer S, Nowak MA (1998) The frequency of resistant mutant virus before antiretroviral therapy. AIDS 12: 461–465.

    Article  PubMed  CAS  Google Scholar 

  23. Imrie A, Beveridge A, Genn W, Vizzrd J, Cooper A (1997) Transmission of Human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. J Infect Dis 175: 1502–1506.

    Article  PubMed  CAS  Google Scholar 

  24. Boucher CAB (1999) HIV-drug resistance tests are here to stay. Cur Opin Cl in Dis

    Google Scholar 

  25. Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MS, Tian H, Hellmann NS, Bandrapalli NI, Digilio L, Branson B, Kahn JO (1998) Sexual transmission of an HIV-i variant resistant to multiple reverse-transcriptase and protease inhibitors. N Eng J Med 339: 307–311.

    Article  CAS  Google Scholar 

  26. Kuritzkes DR, Bell S, Bakhtiari M (1994) Rapid CD4+ cell decline after sexual transmission of a zidovudine-resistant syncytium-inducing isolate of HIV-1. AIDS 8: 1017–1018.

    Article  PubMed  CAS  Google Scholar 

  27. Veenstra J, Schuurman R, cornelissen M, van’t Wout A, Boucher CAB, Schuitemaker H, Goudsmit J, Coutinho RA (1995) Transmission of Zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: Characteristics and natural history of the Virus. Clin Inf Dis 21: 556–560.

    Google Scholar 

  28. Imrie A, Carr A, Duncombe C, Finlayson R, Vizzard J, Law M, Kaldor J, Penny R, Cooper DA and the Sydney primary HIV infection stud group (1996) Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. J Inf Dis 174: 195–198.

    Article  CAS  Google Scholar 

  29. Rubio A, Leal M, Rey C, Pineda JA, Sanchez-Quijano A, Lissen E (1998) Short-term evolution of HIV-1 viraemia and CD4+cell counts in patients who have a primary mutation to zidovudine. AIDS 12: 395–398.

    Article  PubMed  CAS  Google Scholar 

  30. Durant J, Clevenbergh P, Halfon P, Delguidice P, Porsin S, Simoner P, Montagne N, Dohin E, Della- monica P (1998) Can genotype determiantion be useful for individualized adaption of antiretroviral therapy: the VIRADEPT french study. AIDS 12:S16 abstract.

    Google Scholar 

  31. Centers for Disease Control and Prevention (1998) Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendation for postexposure prophylaxis. MMWR 47: 1–33

    Google Scholar 

  32. Anonymous (1993) HIV seroconversion after occupational exposure despite early prophylactic zidovudine therapy. Lancet 341: 889–890.

    Article  Google Scholar 

  33. Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall, Ippolito G, Lot F, McKibben PS, Bell DM and the CDC and prevention needle-stick surveillance group (1997) A case-control study of HIV-seroconversion in health care workers after percutaneous exposure. N Eng J Med 3375; 1485–1490.

    Article  Google Scholar 

  34. Mayers Dl, Yerly S, Perrin L, Imrie A, Cooper DA, Scahcker T, Corey L, Karney WW, Brown A, Rakik A, Harris R, Weislow O, Zhou S and Burke DS (1995) Prevalence and clinical course of persons sero converting with AZT-resistant HIV-1 in Switzerland, Australia and the United States between 1988 and 1994. AIDS Res Hum Retrovir. n(suppl 1)S162.

    Google Scholar 

  35. Rubio A, Leal M. Pineda JA, Caruz A, Luque F, Rey C, Sanchez-Quijano, Lissen E (1997) Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1 infected antiviral-naive patients from 1989–1996. AIDS 11: 118–1186

    Article  Google Scholar 

  36. Sönnerborg A, Johansson B, Ayehunie, Julander I (1993) Transmission of zidovudine-resistant HIV- 1. AIDS 7: 1684–1685.

    Article  Google Scholar 

  37. Brun-Vezinet, Boucher C, Loveday C, Descamps D, Fauveau, Izopet J, Jeffries D, Kaye S (1997) HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. Lancet 350: 983–990.

    Article  PubMed  CAS  Google Scholar 

  38. Gomez-Cano M, Rubio A, Puig T, Perez-Olmeda, Ruiz L, Soriano V, Pineda JA, Zamora L, Zaus N, Clotet B. Leal M (1998) prevalence of genotypic resistance to nucleoside analogues in antiretrovi- ral-naive and antiretroviral experienced HIV-infected patients in Spain. AIDS 12: 1015–1020.

    Google Scholar 

  39. Dietrich U, Ruppach H, Gehring S, Knechten H, Knickmann M, Jager H, Wolf E, Husak R, Orfanos CE, Brede HD, Rubsamen-Waigmann H, von Briesen H. (1997) Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconverters. AIDS 11: 1532–1533.

    PubMed  CAS  Google Scholar 

  40. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Duran M, Tsay J, lp J, Kost R, Farthing C, Markowitz M (i999)Prevalence of HIV-1 drug resistance mutations in newly infected individuals remains stable over a 3 year period. Abstract 277 at the 6th conference on Retroviruses and Opportunistic Infections. Chicago USA.

    Google Scholar 

  41. Donovan R, Berrey M, Corey L, Mayers D (1999) Prevalence of protease inhibitor and reverse transcriptase inhibitor resistance mutations in recent HIV-1 seroconverters in Seattle Abstract 217 at the 6th conference on Retroviruses and Opportunistic Infections. Chicago USA.

    Google Scholar 

  42. Leoncini F, Corsi P, Pozzi M. Zazzi M. Farese A, Vigano S, Ambu S, Bartolozzi D (1998) Prevalence of resistance to drugs in HIV-naive patients. AIDS 12:S4 abstract.

    Google Scholar 

  43. Alexander C, Dong W, Mo T, O’Shaugnessy M, Schechter M, Montaner J, Harrigan PR (1999) Primary antiretroviral resistance in recently infected injection drug users and in drug naive individuals. Abstract 218 at the 6th conference on Retroviruses and Opportunistic Infections. Chicago USA.

    Google Scholar 

Download references

Authors
  1. A. M. J. Wensing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. T. J. M. Benders
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. A. B. Boucher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Dermatologie, Allergologie und Venerologie, Ruhr-Universität Bochum, Gudrunstraße 56, Deutschland

    Norbert H. Brockmeyer , Klaus Hoffmann , G. Reimann , Markus Stücker  & Peter Altmeyer , , ,  & 

  2. Medizinische Klinik III, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland

    R. Brodt

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Wensing, A.M.J., Benders, I.T.J.M., Boucher, C.A.B. (2000). Transmission of Resistant Viruses. In: Brockmeyer, N.H., Hoffmann, K., Reimann, G., Stücker, M., Altmeyer, P., Brodt, R. (eds) HIV-Infekt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59683-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59683-4_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64082-7

  • Online ISBN: 978-3-642-59683-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation